Trabectedin and its potential in the treatment of soft tissue sarcoma

Por Cassier, Philippe A, Dufresne, Armelle, Blay, Jean-Yves, Fayette, Jérôme
Publicado em 2008

Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience

Por Levard, Alice, Derbel, Olfa, Méeus, Pierre, Ranchère, Dominique, Ray-Coquard, Isabelle, Blay, Jean-Yves, Cassier, Philippe A
Publicado em 2013

New developments in treatment of ovarian carcinoma: focus on trabectedin

Por Cassier, Philippe A, Duret, Aude, Trédan, Olivier, Carrabin, Nicolas, Méeus, Pierre, Treilleux, Isabelle, Guastalla, Jean-Paul, Ray-Coquard, Isabelle
Publicado em 2010

Combining chemotherapeutic agents and netrin-1 interference potentiates cancer cell death

Por Paradisi, Andrea, Creveaux, Marion, Gibert, Benjamin, Devailly, Guillaume, Redoulez, Emeline, Neves, David, Cleyssac, Elsa, Treilleux, Isabelle, Klein, Christian, Niederfellner, Gerhard, Cassier, Philippe A, Bernet, Agnès, Mehlen, Patrick
Publicado em 2013

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

Por Cupissol Didier, Rios Maria, Adenis Antoine, Bui Binh, Ray-Coquard Isabelle, Fayette Jerome, Bertucci François, Cassier Philippe A, Blesius Aurore, Pérol David, Blay Jean-Yves, Le Cesne Axel
Publicado em 2011-02-01

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

Por Blesius, Aurore, Cassier, Philippe A, Bertucci, François, Fayette, Jerome, Ray-Coquard, Isabelle, Bui, Binh, Adenis, Antoine, Rios, Maria, Cupissol, Didier, Pérol, David, Blay, Jean-Yves, Le Cesne, Axel
Publicado em 2011

Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer

Por Cassier, Philippe A, Treilleux, Isabelle, Bachelot, Thomas, Ray-Coquard, Isabelle, Bendriss-Vermare, Nathalie, Ménétrier-Caux, Christine, Trédan, Olivier, Goddard-Léon, Sophie, Pin, Jean-Jacques, Mignotte, Hervé, Bathélémy-Dubois, Clarisse, Caux, Christophe, Lebecque, Serge, Blay, Jean-Yves
Publicado em 2011

Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors

Por Molife, L Rhoda, Yan, Li, Vitfell-Rasmussen, Joanna, Zernhelt, Adriane M, Sullivan, Daniel M, Cassier, Philippe A, Chen, Eric, Biondo, Andrea, Tetteh, Ernestina, Siu, Lillian L, Patnaik, Amita, Papadopoulos, Kyriakos P, de Bono, Johann S, Tolcher, Anthony W, Minton, Susan
Publicado em 2014

Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers

Por Perkins, Geraldine, Yap, Timothy A., Pope, Lorna, Cassidy, Amy M., Dukes, Juliet P., Riisnaes, Ruth, Massard, Christophe, Cassier, Philippe A., Miranda, Susana, Clark, Jeremy, Denholm, Katie A., Thway, Khin, Gonzalez De Castro, David, Attard, Gerhardt, Molife, L. Rhoda, Kaye, Stan B., Banerji, Udai, de Bono, Johann S.
Publicado em 2012